Skip to main content
. 2010 Mar 4;15(5):323–331. doi: 10.1159/000289571

Table 1.

Clinical demographics

Subject Etiology Sex Ear implanted Age became deaf, years Age implanted years Age at death years Years deaf Years implanted Months between implantation and last NU-6 test
1 Unknown M L(CL) 47 83 90 36 7 6

2 Temporal bone fracture M L (HS)→ L (N22) 47 53 (L), 57 (L) 67 6 14 14

3 Temporal bone fracture M R(I)→R(I)→R (N22) 71 71 (R), 72 (R), 75 (R) 88 0.25 17 30

4 Temporal bone fracture M R (N22) 65 65 67 0.5 2 25

5 Genetics M L (N24) 49 71 72 22 1 3

6 Mumps, chemotherapy F R(N22)→ R (N22) 72 75 (R), 76 (R) 79 3 4 16

7 Meningogenic labyrinthitis M R(I) 20 65 72 45 7 66

8 Unknown F R (N22) 71 82 85 11 3 144

9 Sudden SNHL F R (N22) 47 59 74 12 15 181

10 Otosclerosis F L (N24) 51 65 69 14 4 16

11 Meningogenic labyrinthitis M L(I) 60 68 71 8 3 25

12 Chronic otitis media F R(3M)→ R (N22) 50 65 (R), 74 (R) 80 15 15 60

13 Unknown M R (N24) 67 82 94 15 12 84

14 Otosclerosis F R(N22)→ L (N24) 56 56 (R), 69 (L) 73 0.17 12 (R), 4(L) 7

15 Otosclerosis M L(I) 65 74 84 9 10 117

16 Sudden SNHL F R(I) 38 40 55 2 15 155

17 Meningogenic labyrinthitis M R(NS)→ L (N22) 65 68 (R), 70 (L) 73 3 5 24

18 Unknown F L (N22) child 54 64 54 10 20

19 Sudden SNHL M R(I) 20 30 47 10 17 144

20 Unknown F L (N24) 84 85 92 1 7 3

21 Ménière's disease M L (N22) 61 81 92 20 11 27

22 Schwannoma M R (N22) 50 59 70 9 11 26

23 Ménière's disease M R (N24) 67 67 70 0.17 3 10

24 Meningogenic labyrinthitis M L(I) 27 61 77 34 16 147

25 Unknown M R (N22) 47 77 84 30 7 48

26 Unknown M R (N22) 55 63 75 8 12 125

27 Unknown M L(CL) 68 72 78 4 6 28

N22 = Nucleus 22; N24 = Nucleus 24; CL = Clarion; I = Ineraid (Richards Symbion); NS = Nucleus single-channel device; HS = House single-channel device; 3M = 3M House single-channel device; SNHL = sensorineural hearing loss.